Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPODURE Biopump for Anemia in CKD
NCT00542568Phase 2Completed
- Sponsor
- Aevi Genomic Medicine
- Start
- Aug 2008
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of MDGN201 in anemia of chronic kidney disease (CKD-A) (3 cohorts), sponsored by Aevi Genomic Medicine. Primary endpoints: Adverse Events at 6 months, Safety Laboratory Values at 6 months and 2 more. Started Aug 2008; status: completed.
02
Drugs
MDGN201
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00542568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542568.